Tomoko Okumura
7PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 14, 2025
Efficacy of Adding Immune Checkpoint Inhibitors to Chemotherapy Plus Bevacizumab in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials.Fumihiko Ando, Akihisa Matsuda, Yuji Miyamoto
|May 25, 2024
Interleukin 21 promotes IgG1+ plasma cell differentiation instead of class switching to IgE via Blimp1 expression.Masaaki Hashiguchi, Tomoko Asatsuma-Okumura, Yoshiko Iwai
|Nov 12, 2021
PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates.Nobuyuki Shimizu, Tomoko Asatsuma-Okumura, Junichi Yamamoto
|Sep 22, 2020
ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells.Junichi Yamamoto, Tetsufumi Suwa, Yuki Murase
|May 17, 2020
Molecular Mechanisms of the Teratogenic Effects of Thalidomide.Tomoko Asatsuma-Okumura, Takumi Ito, Hiroshi Handa
|Oct 09, 2019
p63 is a cereblon substrate involved in thalidomide teratogenicity.Tomoko Asatsuma-Okumura, Hideki Ando, Marco De Simone
Pageof 2
Frequent Collaborators
4 joint publications
Hiroshi Handa
2 joint publications
Takumi Ito
1 joint publications
Masaaki Hashiguchi
1 joint publications
Yoshiko Iwai
1 joint publications
Fumihiko Ando
1 joint publications
Akihisa Matsuda
1 joint publications
Yuji Miyamoto
1 joint publications
Yu Sunakawa
1 joint publications
Shogo Katsura
1 joint publications
Atsushi Yokoyama
